Posts

Innovent deal seeds Spero’s future beyond GSK’s antibiotic, opening an oncology pipeline in 2026

on

Pfizer CFO to depart

on

4 years after FDA snub, GSK partnership propels Spero’s Utebzi across approval finish line

on

Shionogi Receives $119M BARDA Award to Establish US Antibiotic Manufacturing Plant

on

New Ann Arbor Guide Improves UTI Care in Telehealth Era

on

FDA Approves GSK's Gepotidacin (Blujepa) for Uncomplicated Urogenital Gonorrhea

on

Recent advances in AI for antimicrobial resistance (AMR) prevention and control

on

As Drug Resistance Rises, GramEye and GSK Advance New AI-Led Infectious Disease Research

on

GSK, Spero Report Major Phase 3 Win for UTI Antibiotic; Spero's Stock Surges

on

Vaccine-probiotic combo prevents, clears bacterial gut infections in mice in antibiotic alternative test

on